Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial

Effectiveness HAE attack rates In both treatment groups, adjusted patient-reported attack rates showed a decreasing trend over time despite some fluctuations, and improvements were observed after just 1 month of berotralstat treatment ( Fig. 2 A and B).

also in 47,180 other papers